GlassScriptPhysician profile
Claire Kylander
NPI 1003581166
$3,974.94
in general payments reported to CMS, 2019-2025
18 companies · $969 in 2025
The $969 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.52 · 2022: $228 · 2023: $1,456 · 2024: $1,254 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,679.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,102.15 | 2023-2025 | Gemtesa, Myfembree |
| Abbvie INC. | $607.72 | 2021-2025 | |
| Astellas Pharma US INC | $485.01 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $284.13 | 2022-2025 | |
| Medtronic, INC. | $238.40 | 2023-2025 | Interstim |
| 180 Medical, INC. | $189.53 | 2023-2025 | Gentlecath Glide, Cure Catheter, Cure Ultra Catheter |
| Coloplast Corp | $174.61 | 2023-2025 | Saffron, Altis |
| Exeltis, USA INC. | $151.94 | 2022-2024 | Slynd |
| Boston Scientific Corporation | $136.84 | 2025 | Axonics |
| Convatec INC. | $116.53 | 2024 | |
| Millicent US INC | $111.64 | 2023-2025 | Intrarosa |
| Axonics, INC. | $91.24 | 2023-2024 | Axonics |
| Cmp Pharma, INC. | $83.79 | 2022 | |
| Ascend Therapeutics US, LLC | $60.05 | 2023-2024 | |
| Xeris Pharmaceuticals, INC. | $48.22 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $40.17 | 2022 | |
| Integra Lifesciences Corporation | $34.78 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Exact Sciences Corporation | $18.19 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Kylander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.